Header Ads

The Only Good Plan to End the Pandemic Isn’t Going So Well

Hey there, it's Stephanie. For more than a year, Seth Berkley has been saying "no one is safe until everyone is safe." Berkley, an epidemiologist who runs Gavi, a nonprofit that delivers immunizations to poor countries, helped develop the Covax Facility, a public-private partnership aiming to deliver 1.8 billion Covid-19 vaccines to lower-income economies by early 2022.

Unfortunately, as my colleague James Paton and I write for Bloomberg Businessweek, Covax—which was set up to fend off what Berkley calls the threat of a "free-for-all, Lord of the Flies" situation—is nowhere near getting as many doses as it needs. Sure, some wealthy countries, including the U.S., are beginning to kick doses Covax's way. But even that will barely make a dent in plugging the immediate supply gap. 

As cases in the U.S. and Europe decline and vaccines there become plentiful, Berkley says it's dangerous to think anyone is safe. "We're going to have continued evolution of the virus," he says, "and that's just going to come right back and threaten the U.S. as well as the rest of the world." Which leads to an unsettling thought: What if the world isn't actually returning to normal anytime soon? Read my story. —Stephanie Baker

ILLUSTRATION: DEREK ZHENG FOR BLOOMBERG BUSINESSWEEK

ILLUSTRATION: DEREK ZHENG FOR BLOOMBERG BUSINESSWEEK

 

What We're Reading

The Bottom 90% of Americans Are Borrowing From the Top 1%
AMC Became the People's Stock by Not Being a GameStop Remake
Chairman's Firing Is Latest Jolt at Troubled Financial Watchdog
Joby's Plan for Air Taxis Takes Shape
Once Tech's Golden Child, Apple Loses Its Luster as Scrutiny Grows
 

Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else. Learn more.

 

No comments